During the past decade, UCLA Department of Psychiatry and Biobehavioral Sciences conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Department of Psychiatry and Biobehavioral Sciences" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Department of Psychiatry and Biobehavioral Sciences" are "Anxiety Disorders" (1 trials), "Cannabis Use Disorder" (1 trials), "Charcot-Marie-Tooth Disease" (1 trials), "Marijuana Abuse" (1 trials) and "Substance Use Disorders" (1 trials). Many other conditions were trialed in "UCLA Department of Psychiatry and Biobehavioral Sciences" in a lesser frequency.

Most popular intervention types in "UCLA Department of Psychiatry and Biobehavioral Sciences" are "Behavioral" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "(RS)-baclofen, naltrexone hydrochloride and D-sorbitol" (1 trials), "AEF0117" (1 trials), "CALM-SUD" (1 trials), "CUD-AMT" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Department of Psychiatry and Biobehavioral Sciences" are 4 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Department of Psychiatry and Biobehavioral Sciences". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UCLA Department of Psychiatry and Biobehavioral Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Department of Psychiatry and Biobehavioral Sciences, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".